{"ticker": {"uuid": "2c80dfd8-2836-4695-9067-0a9dd4284040", "symbol": "OSX", "name": "Osteopore Limited", "exchange": "ASX", "country": "AU", "sector": "Healthcare", "industry": "Medical Instruments & Supplies"}, "articles": [{"title": "Osteopore Limited (ASX:OSX): How Is This 3D-Printed Bone Regeneration Biotech Advancing Its Commercial Pipeline?", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5wFBVV95cUxOR1E3RUt6d3dKd2VhYWI3R0Q4Rll0d3U3dzhnRGxETTFUQ1RHdXA1ZzRnUm5GNVlWSTdtbTBsQTlUd0pTdnBHbzRManNZd2ZIT1A3azR0QWd6RmlzLUtINDRyOXFpNFhwYTE3WHBRZC1ieUNENTFlX1FpTC1sUHUyZ3RidUFxMURVNlRLU1NFdTNiTXlMWm1waTloM0pxT1hWLUVZbTM5eXNOUTJQdWVYUzh6Q3RNeWpubGJVc2dRcVNYX0xzaExtQ1Z2ckotdE5aMnBBNDBWUVhuMzhlZm5ENFBMY3RRMFE?oc=5", "source_name": "Kalkine", "published_at": "2026-07-10T01:41:00+00:00", "published_display": "10 Jul 2026 01:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Osteopore achieves medical product access in Saudi Arabia", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxOenFGMkI0em9Xb2hfc3I2WHVJYU9FRk5WTU1mZEluUzZhZ2ZJRlFkVG5ONmRmcFRZTjFWT1ZKT3dvSzkyUnVGQVZaMVhTeHJydHdvMXJCRDdUZ3hOZVg3RDA5dmhRWmp2LTNTV0hLX20zLTRzMGUyOTZPU0Y2OXZodFpEUXNTM1RtS0U0ZFFJZzdhbTJaaTZiaw?oc=5", "source_name": "grafa.com", "published_at": "2026-07-06T07:00:00+00:00", "published_display": "06 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Osteopore (ASX:OSX) Gains Momentum Following China Expansion Update", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxPVWpVRzBRQ1hEWlhGcTJySy1aZzBja2VvN0F1b0pId09mVE51VlF6RUlfVERrVE4xZWYtZHU5SmtDZDNsYmdhTENJQVA2bUNybnJhd3RURnJxSVd5Y1VOYkxRZHZwVjgxZlhKZUUwQ3RreGpQWnZaX3prdldBTmdsWWY2bF8tR2pSaTJpYXZ3eVRQQzY1RTM0OXdaUTV2Z1prTDhUR2ZB?oc=5", "source_name": "Kalkine", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Osteopore (ASX:OSX) shares rise by 50% as it cracks the Chinese market", "summary": "", "url": "https://news.google.com/rss/articles/CBMid0FVX3lxTE80bWV0dkNIRU96MndDZ3dia2RYTjl1dFA0Z0hsLXdLcjA3eWlIdnhqeGxVWEd3b05KMGZ3Sm41RXJIai12TjBiNF9UdDY5ODMyT04xaS1XX0czaEZpeVVHZVY5SkE5aWdxNzgyam5aSDZ6M0ZLRmJV?oc=5", "source_name": "Stocks Down Under", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Osteopore secures landmark medical approval In China", "summary": "", "url": "https://news.google.com/rss/articles/CBMikgFBVV95cUxOY2VtS014dFBMQWxlZ0NQaUxFUjZ4aFIyM2xjR1J4TGJ4b1o4Vkhkb1dJbHdacmhROWdxQ1hCOUpfNENpbFY5Qlg4UV9LX2ZZeEdsNy1TWWZOVTk3VGtpTkMzOHZiS1JHWndQQklkVUI4Mzhsanh1WW5JSHVnb0RGdmI0M19DU2QtcU1rSjNtd2lUUQ?oc=5", "source_name": "grafa.com", "published_at": "2026-05-25T07:00:00+00:00", "published_display": "25 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Osteopore (ASX:OSX) is set to crack the Malaysian market - and its bigger than you may think!", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxOM2pVVXd2V1FqT0ItNTFiR3hkRnRoZEo0VW1Wb3R0U2Vxdzd2ZFFMd2dHZEJCaWNrVzNCeUtxOEJjN3hDRWJlNUlhMjRIUmVVbGtWYTBJekdaRzhnRlVSeWJURm1Vbi1vTjYxNjkyZTVrdjNRZ3Y0dkpHZEhyUjM0Sw?oc=5", "source_name": "Stocks Down Under", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Osteopore (ASX:OSX) Stock Analysis: Revenue Growth, Losses, and Future Potential", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxQVnF3cVdUanVUMmplaG5EeVFKNWZ2NTl5MzNkaldXN0V4RHZtaVhVMFZHX1l3NGV2RTdsa0lUWDJFTXlBUmJyaW02WF96ekxRTU1lNHlpZzNSN1pvcUU3Mlg4bzlMWjU3MWpJN2V6ZEFPWVFTWlZXcWJOblc5ekVpR3IyNXlUa3RmZlZXMmtuRWNyci12cVY5X2J1U1JyRWtVb255Tm9pakVJSmpqTmI5NTVZTQ?oc=5", "source_name": "Kalkine", "published_at": "2026-03-30T07:00:00+00:00", "published_display": "30 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Osteopore (ASX:OSX) Attracts Institutional Interest as Advance Opportunities Fund Emerges as Key Shareholder", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3AFBVV95cUxQejRaQkVoZXIybEpkdzRpRzhpYkt0WmZyLWlTSU5ickJlQ3d3VHBWYXFjbklPRUVyakJURWRmU0dyUHFFT2tYbVFNaXBCQUcxVXNPUV9GNlA3X0thbmNJVUxLSW81Y2dLYXB1aG5ZdHpabUYwa2dUREcyWEtSY2Fpb2VRR0FZeGlhMHF0YXdlMXJWZDBXWUlCcFlYbzFPNlJEa2tvb3c3UkxGWUVGcXAwSG9KWHp1Y0dlMHM2cUtHWm9oSWdPX1FZVHQ2LUJRUmgtdUNqZDA1aUVuRTFk?oc=5", "source_name": "Kalkine", "published_at": "2026-03-05T08:00:00+00:00", "published_display": "05 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ASX Runners of the Week: Aus Strategic, Osteopore, Olympio & Riversgold", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxPdXZoSUhfYldNZzBFeEY4S0xMaHI4U3ZuTU54UG5UMkRJcERNYXN3dGNPOE1NYWVnM2hQdnJUb0RuUEk3UnZJcGFrcHhsbDJJREltM2FOVEJIenpVODlIdXcxeU8wNmlTUHk3YW11NEdxZ0dPaFg4cEY4YkhJVHRJc2FDQ3ZzakNPQ3RiWDhtbllUZG5lSlVsZWxqdjM0blo0Y09qNGdxeEdDdjRoeF8tWTVuM0hsOGYyRE5hcUNGWVd5bmg4ZTB4UWVuMXZJdw?oc=5", "source_name": "SMH.com.au", "published_at": "2026-01-23T08:00:00+00:00", "published_display": "23 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ASX Runners of the Week: Zelira, Linq, Dalaroo and Osteopore", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxPenVkQnNDYW81T2xFZmNES2Uxem5fbG1FM3VVV3NLUjlUN1kxdERqQzMzOUd5UUI3NWpwRmtETlVNYldwdzhWT2RSekVjbW1RXzVtSEJZZlJCc3kySlhmZ2Nzakx3dGJUenlpaGtYTU9KOWI0bHlBNS1JNVZlS01mcFFzcjR3NVFyUm95WW83akVLbVREU1ZSTDdOTEM5aFdLZW9OV3hOLXpDWkhmUFpZbXNHM0NCblFVUldueg?oc=5", "source_name": "SMH.com.au", "published_at": "2026-01-16T08:00:00+00:00", "published_display": "16 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insights: Osteopore Ltd (ASX:OSX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiUEFVX3lxTFB2ZE1HdFRhZ1pWM1pIWFhkVHU4cEVnRHZlMURLNWZFU3ZtX3ZCdTdoVFFNTkF1Vll1N1NXUnRJd3BzcUFKeGVzaFNuS3lETzdw?oc=5", "source_name": "smallcaps.com.au", "published_at": "2025-10-30T15:59:27+00:00", "published_display": "30 Oct 2025 15:59", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Osteopore enhances strategic refocus with early cessation of dental grant project", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxOSVB0dzNCcW11Xy1yS3p3NkFtbGZGREZ0VkQ2M3ZkQTV6VS1zYnFTeHA0NHhFb0FEODN4VXJ5S1dOc2t0R3Nkc1NNY3poN1ItMzZlZTIxbXdRSkowd1NWWUtLTWc5b3FEazFKNURpTy1GLU5IOEt2UGxDdDlBTFJQLUJZd2QzTUhyWEFFYmdLTWlaQ0NaVlZVb2trajBrbm5sUktjWlFoRXJCSEpSN3k5b2tkY01vcHJ6?oc=5", "source_name": "BiotechDispatch", "published_at": "2025-03-20T07:00:00+00:00", "published_display": "20 Mar 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Case Study: Osteopore International\u2019s bright future as a regenerative medicine leader", "summary": "", "url": "https://news.google.com/rss/articles/CBMidkFVX3lxTE13aFR6Vjc1NUg2N2dfeWZwMDViaEJwQUtlcmduSGVnY09FdUFQWmdid1ozLXRIeHlJTWtUWHVGTUxrdEVyREEwdjZDODNPb2MtUUM1M0xpRlZNQU9Rd0JodVVqYnRqLXEzZEdaU25fbDl3OWhLUHc?oc=5", "source_name": "RSM Global", "published_at": "2024-07-05T01:52:57+00:00", "published_display": "05 Jul 2024 01:52", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ASX Small Caps Lunch Wrap: Osteopore\u2019s gone 1000% bananas, and here\u2019s the rest of the news.", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxQVlVGdV80MnBDVFpERjNfVUhuUkY3a1ZhU0RWWGo2akVZdlV5UDVpM0FQbHIyUFRGcEFlN2puc2hJaWx1WHp1aFFDTGlVVlJ5U29obkdtRk43Vy1YV1FHS19QVmpIRkQxdm9GWE9PbFgyc0VKSmQyLVBMVlJUVHp6d0Q1TGtFWHZzeFZDUjlRc1hWRHIyZllKdVplT2JDUHZsemtvWnp0NVY2VkJnVHRJNURRdndIc2s?oc=5", "source_name": "Stockhead", "published_at": "2024-03-27T07:00:00+00:00", "published_display": "27 Mar 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Osteopore Limited (ASX: OSX) - Share Price", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxPQVdIUXhmRzR4WmFDek9HZTdDWDl4ZlpJeEZyVi1HeU43R1FkYmFib1JGV282YXExVzZMQmg3Xy1KMXFfRUVScmxUTjNwaHR5b0Z5VlNXbWdac2xOMlBsRjkxLVJxNEZadjhCSkpFRnQzdW5rUUY2SGYyMWdUVHZWdVhybEJqMDFRT3Mw?oc=5", "source_name": "intelligentinvestor.com.au", "published_at": "2020-02-05T04:04:53+00:00", "published_display": "05 Feb 2020 04:04", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OSX Stock Price and Chart \u2014 ASX:OSX", "summary": "", "url": "https://news.google.com/rss/articles/CBMiV0FVX3lxTE5pWTNuYVVYcGtnUFZjXzF0bU54N3lZVTRmczl2VzdVelNBY3ltZ2dGQl83dU5OQzJRMENxZ0FES2FUWGFZTlNaV2JVYlZuQmJ1OG5qWkRyUQ?oc=5", "source_name": "TradingView", "published_at": "2019-09-26T16:05:14+00:00", "published_display": "26 Sep 2019 16:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Osteopore Limited (ASX:OSX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMie0FVX3lxTE1hM3VfWk1wWXZLWUJuUXQ3WFJKeDNUamtzZG5sWFRadmZLRDQwaTBJOE5PR0FuX3N2U2l1eVBNRFZDYkdtQXgyNkk2SVdtbmxqMXZfSEkxU09CU0hhUDJfczZGZ1o2RE9vRzNYWVNMQWZRWjVuUTUyZDF1QQ?oc=5", "source_name": "intelligentinvestor.com.au", "published_at": "2019-09-24T12:46:59+00:00", "published_display": "24 Sep 2019 12:46", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Perth-based bone healing biotech company Osteopore soars on ASX debut", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxPZ2Z4R2Q3MVUwVml6ZTRzeDEzR0lmRWNtQ084OWJkVzdLaklIRjFmT01UR0paRDRzRUV5MWl0cWtqNklNTGVCNTZYaU9mY2JQcE40VmtkYlN1RlM3Y0V5WXY3Z2k2WkVjX1lfcVZqTTdvcGpfU21NekpGQlNmd3EtSjVIS05DYnJ5ZEtjQUtTaklZQ1BycDc5OUNiRXNMdDhsUl9ISjNRa01zbWVMRVpEQnozUVg0QUExcVJVWFdQaWs0TGkwcWRZd2wzMHM?oc=5", "source_name": "SMH.com.au", "published_at": "2019-09-23T07:00:00+00:00", "published_display": "23 Sep 2019 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Osteopore Limited (ASX:OSX): How Is This 3D-Printed Bone Regeneration Biotech Advancing Its Commercial Pipeline?", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5wFBVV95cUxOR1E3RUt6d3dKd2VhYWI3R0Q4Rll0d3U3dzhnRGxETTFUQ1RHdXA1ZzRnUm5GNVlWSTdtbTBsQTlUd0pTdnBHbzRManNZd2ZIT1A3azR0QWd6RmlzLUtINDRyOXFpNFhwYTE3WHBRZC1ieUNENTFlX1FpTC1sUHUyZ3RidUFxMURVNlRLU1NFdTNiTXlMWm1waTloM0pxT1hWLUVZbTM5eXNOUTJQdWVYUzh6Q3RNeWpubGJVc2dRcVNYX0xzaExtQ1Z2ckotdE5aMnBBNDBWUVhuMzhlZm5ENFBMY3RRMFE?oc=5", "source_name": "Kalkine", "published_at": "2026-07-10T01:41:00+00:00", "published_display": "10 Jul 2026 01:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Osteopore achieves medical product access in Saudi Arabia", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxOenFGMkI0em9Xb2hfc3I2WHVJYU9FRk5WTU1mZEluUzZhZ2ZJRlFkVG5ONmRmcFRZTjFWT1ZKT3dvSzkyUnVGQVZaMVhTeHJydHdvMXJCRDdUZ3hOZVg3RDA5dmhRWmp2LTNTV0hLX20zLTRzMGUyOTZPU0Y2OXZodFpEUXNTM1RtS0U0ZFFJZzdhbTJaaTZiaw?oc=5", "source_name": "grafa.com", "published_at": "2026-07-06T07:00:00+00:00", "published_display": "06 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Osteopore (ASX:OSX) Gains Momentum Following China Expansion Update", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxPVWpVRzBRQ1hEWlhGcTJySy1aZzBja2VvN0F1b0pId09mVE51VlF6RUlfVERrVE4xZWYtZHU5SmtDZDNsYmdhTENJQVA2bUNybnJhd3RURnJxSVd5Y1VOYkxRZHZwVjgxZlhKZUUwQ3RreGpQWnZaX3prdldBTmdsWWY2bF8tR2pSaTJpYXZ3eVRQQzY1RTM0OXdaUTV2Z1prTDhUR2ZB?oc=5", "source_name": "Kalkine", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Osteopore (ASX:OSX) shares rise by 50% as it cracks the Chinese market", "summary": "", "url": "https://news.google.com/rss/articles/CBMid0FVX3lxTE80bWV0dkNIRU96MndDZ3dia2RYTjl1dFA0Z0hsLXdLcjA3eWlIdnhqeGxVWEd3b05KMGZ3Sm41RXJIai12TjBiNF9UdDY5ODMyT04xaS1XX0czaEZpeVVHZVY5SkE5aWdxNzgyam5aSDZ6M0ZLRmJV?oc=5", "source_name": "Stocks Down Under", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Osteopore secures landmark medical approval In China", "summary": "", "url": "https://news.google.com/rss/articles/CBMikgFBVV95cUxOY2VtS014dFBMQWxlZ0NQaUxFUjZ4aFIyM2xjR1J4TGJ4b1o4Vkhkb1dJbHdacmhROWdxQ1hCOUpfNENpbFY5Qlg4UV9LX2ZZeEdsNy1TWWZOVTk3VGtpTkMzOHZiS1JHWndQQklkVUI4Mzhsanh1WW5JSHVnb0RGdmI0M19DU2QtcU1rSjNtd2lUUQ?oc=5", "source_name": "grafa.com", "published_at": "2026-05-25T07:00:00+00:00", "published_display": "25 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Osteopore (ASX:OSX) is set to crack the Malaysian market - and its bigger than you may think!", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxOM2pVVXd2V1FqT0ItNTFiR3hkRnRoZEo0VW1Wb3R0U2Vxdzd2ZFFMd2dHZEJCaWNrVzNCeUtxOEJjN3hDRWJlNUlhMjRIUmVVbGtWYTBJekdaRzhnRlVSeWJURm1Vbi1vTjYxNjkyZTVrdjNRZ3Y0dkpHZEhyUjM0Sw?oc=5", "source_name": "Stocks Down Under", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Osteopore (ASX:OSX) Stock Analysis: Revenue Growth, Losses, and Future Potential", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxQVnF3cVdUanVUMmplaG5EeVFKNWZ2NTl5MzNkaldXN0V4RHZtaVhVMFZHX1l3NGV2RTdsa0lUWDJFTXlBUmJyaW02WF96ekxRTU1lNHlpZzNSN1pvcUU3Mlg4bzlMWjU3MWpJN2V6ZEFPWVFTWlZXcWJOblc5ekVpR3IyNXlUa3RmZlZXMmtuRWNyci12cVY5X2J1U1JyRWtVb255Tm9pakVJSmpqTmI5NTVZTQ?oc=5", "source_name": "Kalkine", "published_at": "2026-03-30T07:00:00+00:00", "published_display": "30 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Osteopore (ASX:OSX) Attracts Institutional Interest as Advance Opportunities Fund Emerges as Key Shareholder", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3AFBVV95cUxQejRaQkVoZXIybEpkdzRpRzhpYkt0WmZyLWlTSU5ickJlQ3d3VHBWYXFjbklPRUVyakJURWRmU0dyUHFFT2tYbVFNaXBCQUcxVXNPUV9GNlA3X0thbmNJVUxLSW81Y2dLYXB1aG5ZdHpabUYwa2dUREcyWEtSY2Fpb2VRR0FZeGlhMHF0YXdlMXJWZDBXWUlCcFlYbzFPNlJEa2tvb3c3UkxGWUVGcXAwSG9KWHp1Y0dlMHM2cUtHWm9oSWdPX1FZVHQ2LUJRUmgtdUNqZDA1aUVuRTFk?oc=5", "source_name": "Kalkine", "published_at": "2026-03-05T08:00:00+00:00", "published_display": "05 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ASX Runners of the Week: Aus Strategic, Osteopore, Olympio & Riversgold", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxPdXZoSUhfYldNZzBFeEY4S0xMaHI4U3ZuTU54UG5UMkRJcERNYXN3dGNPOE1NYWVnM2hQdnJUb0RuUEk3UnZJcGFrcHhsbDJJREltM2FOVEJIenpVODlIdXcxeU8wNmlTUHk3YW11NEdxZ0dPaFg4cEY4YkhJVHRJc2FDQ3ZzakNPQ3RiWDhtbllUZG5lSlVsZWxqdjM0blo0Y09qNGdxeEdDdjRoeF8tWTVuM0hsOGYyRE5hcUNGWVd5bmg4ZTB4UWVuMXZJdw?oc=5", "source_name": "SMH.com.au", "published_at": "2026-01-23T08:00:00+00:00", "published_display": "23 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ASX Runners of the Week: Zelira, Linq, Dalaroo and Osteopore", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxPenVkQnNDYW81T2xFZmNES2Uxem5fbG1FM3VVV3NLUjlUN1kxdERqQzMzOUd5UUI3NWpwRmtETlVNYldwdzhWT2RSekVjbW1RXzVtSEJZZlJCc3kySlhmZ2Nzakx3dGJUenlpaGtYTU9KOWI0bHlBNS1JNVZlS01mcFFzcjR3NVFyUm95WW83akVLbVREU1ZSTDdOTEM5aFdLZW9OV3hOLXpDWkhmUFpZbXNHM0NCblFVUldueg?oc=5", "source_name": "SMH.com.au", "published_at": "2026-01-16T08:00:00+00:00", "published_display": "16 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insights: Osteopore Ltd (ASX:OSX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiUEFVX3lxTFB2ZE1HdFRhZ1pWM1pIWFhkVHU4cEVnRHZlMURLNWZFU3ZtX3ZCdTdoVFFNTkF1Vll1N1NXUnRJd3BzcUFKeGVzaFNuS3lETzdw?oc=5", "source_name": "smallcaps.com.au", "published_at": "2025-10-30T15:59:27+00:00", "published_display": "30 Oct 2025 15:59", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Osteopore enhances strategic refocus with early cessation of dental grant project", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxOSVB0dzNCcW11Xy1yS3p3NkFtbGZGREZ0VkQ2M3ZkQTV6VS1zYnFTeHA0NHhFb0FEODN4VXJ5S1dOc2t0R3Nkc1NNY3poN1ItMzZlZTIxbXdRSkowd1NWWUtLTWc5b3FEazFKNURpTy1GLU5IOEt2UGxDdDlBTFJQLUJZd2QzTUhyWEFFYmdLTWlaQ0NaVlZVb2trajBrbm5sUktjWlFoRXJCSEpSN3k5b2tkY01vcHJ6?oc=5", "source_name": "BiotechDispatch", "published_at": "2025-03-20T07:00:00+00:00", "published_display": "20 Mar 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Case Study: Osteopore International\u2019s bright future as a regenerative medicine leader", "summary": "", "url": "https://news.google.com/rss/articles/CBMidkFVX3lxTE13aFR6Vjc1NUg2N2dfeWZwMDViaEJwQUtlcmduSGVnY09FdUFQWmdid1ozLXRIeHlJTWtUWHVGTUxrdEVyREEwdjZDODNPb2MtUUM1M0xpRlZNQU9Rd0JodVVqYnRqLXEzZEdaU25fbDl3OWhLUHc?oc=5", "source_name": "RSM Global", "published_at": "2024-07-05T01:52:57+00:00", "published_display": "05 Jul 2024 01:52", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ASX Small Caps Lunch Wrap: Osteopore\u2019s gone 1000% bananas, and here\u2019s the rest of the news.", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxQVlVGdV80MnBDVFpERjNfVUhuUkY3a1ZhU0RWWGo2akVZdlV5UDVpM0FQbHIyUFRGcEFlN2puc2hJaWx1WHp1aFFDTGlVVlJ5U29obkdtRk43Vy1YV1FHS19QVmpIRkQxdm9GWE9PbFgyc0VKSmQyLVBMVlJUVHp6d0Q1TGtFWHZzeFZDUjlRc1hWRHIyZllKdVplT2JDUHZsemtvWnp0NVY2VkJnVHRJNURRdndIc2s?oc=5", "source_name": "Stockhead", "published_at": "2024-03-27T07:00:00+00:00", "published_display": "27 Mar 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Osteopore Limited (ASX: OSX) - Share Price", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxPQVdIUXhmRzR4WmFDek9HZTdDWDl4ZlpJeEZyVi1HeU43R1FkYmFib1JGV282YXExVzZMQmg3Xy1KMXFfRUVScmxUTjNwaHR5b0Z5VlNXbWdac2xOMlBsRjkxLVJxNEZadjhCSkpFRnQzdW5rUUY2SGYyMWdUVHZWdVhybEJqMDFRT3Mw?oc=5", "source_name": "intelligentinvestor.com.au", "published_at": "2020-02-05T04:04:53+00:00", "published_display": "05 Feb 2020 04:04", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OSX Stock Price and Chart \u2014 ASX:OSX", "summary": "", "url": "https://news.google.com/rss/articles/CBMiV0FVX3lxTE5pWTNuYVVYcGtnUFZjXzF0bU54N3lZVTRmczl2VzdVelNBY3ltZ2dGQl83dU5OQzJRMENxZ0FES2FUWGFZTlNaV2JVYlZuQmJ1OG5qWkRyUQ?oc=5", "source_name": "TradingView", "published_at": "2019-09-26T16:05:14+00:00", "published_display": "26 Sep 2019 16:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Osteopore Limited (ASX:OSX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMie0FVX3lxTE1hM3VfWk1wWXZLWUJuUXQ3WFJKeDNUamtzZG5sWFRadmZLRDQwaTBJOE5PR0FuX3N2U2l1eVBNRFZDYkdtQXgyNkk2SVdtbmxqMXZfSEkxU09CU0hhUDJfczZGZ1o2RE9vRzNYWVNMQWZRWjVuUTUyZDF1QQ?oc=5", "source_name": "intelligentinvestor.com.au", "published_at": "2019-09-24T12:46:59+00:00", "published_display": "24 Sep 2019 12:46", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Perth-based bone healing biotech company Osteopore soars on ASX debut", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxPZ2Z4R2Q3MVUwVml6ZTRzeDEzR0lmRWNtQ084OWJkVzdLaklIRjFmT01UR0paRDRzRUV5MWl0cWtqNklNTGVCNTZYaU9mY2JQcE40VmtkYlN1RlM3Y0V5WXY3Z2k2WkVjX1lfcVZqTTdvcGpfU21NekpGQlNmd3EtSjVIS05DYnJ5ZEtjQUtTaklZQ1BycDc5OUNiRXNMdDhsUl9ISjNRa01zbWVMRVpEQnozUVg0QUExcVJVWFdQaWs0TGkwcWRZd2wzMHM?oc=5", "source_name": "SMH.com.au", "published_at": "2019-09-23T07:00:00+00:00", "published_display": "23 Sep 2019 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 71, "total_relevant": 18, "sentiment_summary": {"positive": 1, "negative": 0, "neutral": 17, "score": 52, "total": 18, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 91, "events": [{"event": "general", "label": "Market update", "weight": 8.8, "count": 16}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 0.55, "count": 1}, {"event": "earnings", "label": "Earnings", "weight": 0.55, "count": 1}], "positive_events": 1, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 0.01, "latest_week": "2026-07-10", "one_week_move": 25.0, "four_week_move": 25.0, "twelve_week_move": -16.7, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.323389, "market_dynamics_buy_signal": false, "relative_strength": -43.589701, "fair_value_gap": -97.5, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 26.9621, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+25.0% over one week, +25.0% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "positive", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 64, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Kalkine", "count": 4}, {"label": "SMH.com.au", "count": 3}, {"label": "grafa.com", "count": 2}, {"label": "Stocks Down Under", "count": 2}, {"label": "intelligentinvestor.com.au", "count": 2}, {"label": "smallcaps.com.au", "count": 1}, {"label": "BiotechDispatch", "count": 1}, {"label": "RSM Global", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 18}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 16}, {"label": "Regulatory and legal", "count": 1}, {"label": "Earnings", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "52/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "positive", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "91/100 classification confidence."}, {"label": "Company focus", "value": "18", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+25.0% over one week, +25.0% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Osteopore Limited (ASX:OSX): How Is This 3D-Printed Bone Regeneration Biotech Advancing Its Commercial Pipeline?"}], "updated_at": "2026-07-16T22:50:14.212779+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}